Work

Early Reduction of Glucose Consumption Is a Biomarker of Kinase Inhibitor Efficacy Which Can Be Reversed with GLUT1 Overexpression in Lung Cancer Cells

Year: 2022

Type: article

Source: Molecular Imaging and Biology

DOI: 10.1007/s11307-022-01782-6

Authors: Chiara Ghezzi, Stefani Perez, Kaitlin Ryan, Alicia Wong, Bao Ying Chen, Robert Damoiseaux, Peter M. Clark

Institutions: University of California, Los Angeles, California NanoSystems Institute

Language: English

Topic: Cancer, Hypoxia, and Metabolism

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute, National Center for Advancing Translational Sciences, Jonsson Comprehensive Cancer Center, Clinical and Translational Science Institute, University of California, Los Angeles, Jonsson Cancer Center Foundation

Awards: G1545794908, UCLA Clinical and Translational Science Institute, G5699131004, G9000261587, Cancer Center Support Grant, UCLA Clinical and Translational Science Institute

OpenAlex ID: W4307210682

FWCI: 0.738

Cites: 51

Cited by: 7

Related to: 10